Latest News
Madison Dearborn Partners to Acquire CDMO Alcami
Tuesday 05 June 2018

5 June 2018 - US-based pharmaceutical and biotechnology services provider Alcami Corp has reached an agreement to be majority acquired by private equity firm Madison Dearborn Partners, LLC, the company said.

MDP, a leading private equity firm based in Chicago, will acquire a majority ownership position in Alcami from existing shareholder Ares Capital Corp. (NASDAQ: ARCC).

Alcami's management team, led by chief executive officer, president, and chairman, Dr. Stephan Kutzer, will continue to guide the company.

The transaction is expected to be completed in 3Q18, pending customary closing conditions.

Headquartered within Research Triangle Park (RTP) in Durham, North Carolina, with 10 locations across the globe, Alcami is a CDMO and the first company to provide a solution tailored to small and mid-size pharmaceutical and biotechnology companies.

The company provides fully-integrated end-to-end outsourcing opportunities, which offer a faster pathway for products through the clinic toward commercialisation, as well as individualized development, and manufacturing services.

Alcami's services include active pharmaceutical ingredient development and manufacturing, solid state chemistry, formulation development, analytical development and testing services, drug product manufacturing (oral solid dose and parenteral), and packaging and stability services.

As part of the transaction, Ares Capital is acting as lead debt financing arranger, and is maintaining a minority equity position in the company.

Alcami is a fully integrated end-to-end contract development and manufacturing organization headquartered in North Carolina, with executive offices in Durham and Wilmington.

With approximately 1,000 employees operating at 10 global locations, Alcami provides services to small and mid-size pharmaceutical and biotechnology companies.

William Blair and Company is Alcami's exclusive financial advisor, while Barclays and Jefferies LLC provided financial advice to MDP.
Date Published: 05/06/2018
Target: Alcami Corp
Country: USA
Sector: Pharmaceuticals
Type: LBO
Status: Agreed
Vendor: Ares Capital Corp
Buyer: Madison Dearborn Partners
Buyer Advisor: Barclays and Jefferies
Terms of the deal were not disclosed